2026年9月7日，归创通桥医疗科技股份有限公司（股票代码：02190）公告，于当日在香港联合交易所有限公司场内回购了53,500股H股，约占公司现有已发行股本的0.0162%。本次回购的每股价格介乎21.16港元至22.04港元，总金额为约113.90万港元。
本次回购完成前，公司已发行股份为323,200,613股，库存股为13,150,131股，总股本为336,350,744股。回购完成后，公司已发行股份变更为323,147,113股，库存股上升至13,203,631股，总股本仍为336,350,744股。本次回购股份将继续以库存股形式持有。
据公告，归创通桥此前于2026年5月13日通过了购回授权，授权购回股数为32,715,311股。截至本次回购，基于前期已于交易所及其他证券交易所回购共4,307,000股，占购回授权通过当日已发行股份数量的1.2859%。公司确认已遵守香港联交所证券上市规则及相关法律法规的各项规定。公告由董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.